Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

More Fisticuffs At Phar Mor


In Business This Week

MORE FISTICUFFS AT PHAR-MOR

Deep-discount drug retailer Phar-Mor, hobbled by charges that two senior executives engaged in fraud and embezzlement leading to a $350 million write-off, made its own Chapter 11 filing on Aug. 17. The 300-store chain won court approval to spend $50 million in cash that had been collateral for its lenders. Antonio Alvarez, interim chief financial officer, says that's enough to operate while Phar-Mor tries to develop a game plan for the Christmas season.

Meanwhile, the legal battle over who gets the blame for Phar-Mor's troubles has begun. Phar-Mor sued former auditor Coopers & Lybrand, accusing it of negligence in failing to uncover the fraud. C&L filed a countersuit.EDITED BY DEIDRE A. DEPKE


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus